information on new approvals and medication safety
Medical Device Safety Concerns Rheumatologists
Are recent controversies over metal-on-metal hip replacements and an IOM report cause for worry?
FDA Seeks Comments on Drug Shortages
As reported last month (“Rheumatologists Struggle with Drug Shortages,” October 2011, p. 51), a bill (S. 296) proposed in the U.S. Senate would require drug manufacturers to notify the U.S. Food and Drug Administration (FDA) of factors that might lead to a drug shortage.
Clinical Trials Go Global
As medical research expands to the global population, will trial results sill apply to U.S. populations?
Drug Updates
Information on new approvals and medication safety
Rheumatologists Struggle with Drug Shortages
While not yet at a ‘catastrophic’ level, shortages are becoming more common
Drug Updates
Information on new approvals and medication safety
High Cost, No Benefit
Why are so many brand-name drugs approved after generic versions become available?
Drug Updates
Information on New Approvals and Medication Safety
Drug Updates
Information on New Approvals and Medication Safety